The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

por Huang, Yuhe, Hong, Weiqi, Wei, Xiawei
Publicado 2022

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants

por Ao, Danyi, He, Xuemei, Hong, Weiqi, Wei, Xiawei
Publicado 2023

Pulmonary vascular system: A vulnerable target for COVID‐19

por Ai, Jiayuan, Hong, Weiqi, Wu, Min, Wei, Xiawei
Publicado 2021

Molecular mechanisms and therapeutic target of NETosis in diseases

por Huang, Jiayu, Hong, Weiqi, Wan, Meihua, Zheng, Limin
Publicado 2022

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism

por Hong, Weiqi, Mo, Fei, Zhang, Ziqi, Huang, Mengyuan, Wei, Xiawei
Publicado 2020

The challenges of COVID‐19 Delta variant: Prevention and vaccine development

por He, Xuemei, He, Cai, Hong, Weiqi, Zhang, Kang, Wei, Xiawei
Publicado 2021

Animal models for SARS‐CoV‐2 infection and pathology

por Bi, Zhenfei, Hong, Weiqi, Yang, Jingyun, Lu, Shuaiyao, Peng, Xiaozhong
Publicado 2021

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

por He, Xuemei, Hong, Weiqi, Pan, Xiangyu, Lu, Guangwen, Wei, Xiawei
Publicado 2021

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

por Li, Hongyi, Yang, Yang, Hong, Weiqi, Huang, Mengyuan, Wu, Min, Zhao, Xia
Publicado 2020

Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection

por Tang, Fan, Tie, Yan, Hong, Weiqi, Wei, Yuquan, Tu, Chongqi, Wei, Xiawei
Publicado 2020

Recent progress in targeted delivery vectors based on biomimetic nanoparticles

por Chen, Li, Hong, Weiqi, Ren, Wenyan, Xu, Ting, Qian, Zhiyong, He, Zhiyao
Publicado 2021

Neurological complications and infection mechanism of SARS-CoV-2

por Wan, Dandan, Du, Tingfu, Hong, Weiqi, Chen, Li, Que, Haiying, Lu, Shuaiyao, Peng, Xiaozhong
Publicado 2021

Secular Difference in Body Mass Index From 2014 to 2020 in Chinese Older Adults: A Time-Series Cross-Sectional Study

por Jiang, Ying, Zhang, Xiaomin, Xu, Tianwei, Hong, Weiqi, Chen, Zhiqi, Gao, Xiang, Xu, Renying
Publicado 2022

JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis

por Chen, Siyuan, Wang, Manni, Lu, Tianqi, Liu, Yu, Hong, Weiqi, He, Xuemei, Cheng, Yuan, Liu, Jian, Wei, Yuquan, Wei, Xiawei
Publicado 2023

A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome

por Hong, Weiqi, Yang, Jingyun, Bi, Zhenfei, He, Cai, Lei, Hong, Yu, Wenhai, Yang, Yun, Fan, Changfa, Lu, Shuaiyao, Peng, Xiaozhong, Wei, Xiawei
Publicado 2021

Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice

por Bi, Zhenfei, Hong, Weiqi, Que, Haiying, He, Cai, Ren, Wenyan, Yang, Jingyun, Lu, Tianqi, Chen, Li, Lu, Shuaiyao, Peng, Xiaozhong, Wei, Xiawei
Publicado 2021

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2

por He, Cai, Alu, Aqu, Lei, Hong, Yang, Jingyun, Hong, Weiqi, Song, Xiangrong, Li, Jiong, Yang, Li, Wang, Wei, Shen, Guobo, Lu, Guangwen, Wei, Xiawei
Publicado 2023

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2

por Lei, Hong, Alu, Aqu, Yang, Jingyun, He, Cai, Hong, Weiqi, Cheng, Zesheng, Yang, Li, Li, Jiong, Wang, Zhenling, Wang, Wei, Lu, Guangwen, Wei, Xiawei
Publicado 2020

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response

por He, Cai, He, Xuemei, Yang, Jingyun, Lei, Hong, Hong, Weiqi, Song, Xiangrong, Yang, Li, Li, Jiong, Wang, Wei, Shen, Guobo, Lu, Guangwen, Wei, Xiawei
Publicado 2022

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment

por Que, Haiying, Hong, Weiqi, Lan, Tianxia, Zeng, Hao, Chen, Li, Wan, Dandan, Bi, Zhenfei, Ren, Wenyan, Luo, Min, Yang, Jingyun, He, Cai, Zhong, Ailing, Wei, Xiawei
Publicado 2022